Question 1

How do I set a price alert for PTGX?

Accepted Answer

To set a PTGX price alert on Stock Alarm Pro, navigate to the PTGX quote page, select "Set Alert," choose your trigger type (price target, % move, RSI level, MACD, or volume breakout), and set your delivery channel. Stock Alarm Pro supports instant push notifications, SMS, and automated phone call alerts.

Question 2

Can I get phone call alerts for PTGX?

Accepted Answer

Yes. Stock Alarm Pro provides real-time automated phone call alerts for PTGX. Phone call alerts ensure you are immediately awakened or interrupted during critical volatility events, overnight earnings moves, or strict stop-loss levels when silent push notifications might be overlooked.

Question 3

What types of alerts can I set for Protagonist Therapeutics Inc?

Accepted Answer

Stock Alarm Pro supports over 125 trigger types for PTGX: price target alerts (above/below target), intraday percentage moves, RSI overbought/oversold levels, 50-day and 200-day moving average crossovers (golden cross / death cross), relative volume (RVOL) spikes, confirmed earnings date releases, and SEC Form-4 insider transaction filings.

Question 4

How quickly will I be notified about PTGX price changes?

Accepted Answer

PTGX alerts are evaluated continuously in real-time against live market telemetry. Notifications are dispatched within sub-second latency via push notifications, SMS, or phone calls as soon as your trigger condition is met across regular, pre-market, and after-hours trading sessions.

Question 5

Is Stock Alarm Pro free to use for PTGX alerts?

Accepted Answer

Yes, Stock Alarm Pro offers a free tier that includes 3 active price alerts for PTGX and other stocks. Full Pro membership is $20/month or $168/year with a 7-day free trial, unlocking unlimited alerts, phone call delivery, SMS, all 125+ technical indicators, institutional screeners, and real-time market telemetry across web, iOS, and Android.

Metric	FY2025	FY2026E	FY2027E
Revenue	$46M	$550M	$205M
Rev. Growth	-89.4%	+1094%	-62.8%
EPS	$-2.05	$4.69	$-0.39
EPS Growth	-146%	+329%	-108%
P/E (fwd)	—	28.8×	—

Metric	FY2025	FY2026E	FY2027E
Revenue	$46M	$550M	$205M
Rev. Growth	-89.4%	+1094%	-62.8%
EPS	$-2.05	$4.69	$-0.39
EPS Growth	-146%	+329%	-108%
P/E (fwd)	—	28.8×	—

Protagonist Therapeutics (PTGX)

Revenue Outlook

What Moves the Stock

PTGX Chart

My Notes

One Sentence Summary:

Explore More

S&P 500 Sector Leaderboards

Fundamental Metric Rankings